Amyloid β-peptide polymerization studied using fluorescence correlation spectroscopy

Chemistry and Biology

Volumn 6, Issue 1, 1999, Pages 53-62

  Tjernberg, Lars O ^a   Pramanik, Aladdin ^b   Björling, Sofie ^b   Thyberg, Per ^b   Thyberg, Johan ^b   Nordstedt, Christer ^a   Berndt, Kurt D ^b   Terenius, Lars ^a   Rigler, Rudolf ^b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Alzheimer's disease; Amyloid peptide; Fluorescence correlation spectroscopy; Polymerization

Indexed keywords

EID: 0032797389     PISSN: 10745521     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-5521(99)80020-9     Document Type: Article

References (58)

1. Glenner, G.G. & Wong, C.W. (1984). Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem. Biophys. Res. Commun. 120, 885-890.
2. Masters, C.L., Simms, G., Weinman, N.A., Multhaup, G., McDonald, B.L. & Beyreuther, K. (1985). Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc. Natl Acad. Sci. USA 82, 4245-4249.
3. Selkoe, D.J. (1994). Cell biology of the amyloid β-protein precursor and the mechanism of Alzheimer's disease. Annu. Rev. Cell. Biol. 10, 373-403.
4. Goate, A., et al., & Hardy, J. (1991 ). Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheiner's disease. Nature 349, 704-706.
5. Mullan, M., et al., & Crawford, F. (1992). A pathogenic mutation for probable Alzheimer's disease in the APP gene at the amino terminus of β-amyloid. Nat. Genet. 1, 345-347.
6. Sherrington, R., et al., & St George-Hyslop, P.H. (1995). Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature 375, 754-760.
7. Rogaev, E.I., et al., & St George-Hyslop, P.H. (1995). Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene. Nature 376, 775-778.
8. Levy-Lahad, E., et al., & Schellenberg, G.D. (1995). A familial Alzheimer's disease locus on chromosome 1. Science 269, 970-973.
9. Scheuner, D., et al., & Younkin, S. (1996). Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease. Nat. Med. 2, 864-870.
10. Games, D., et al., & Zhao, J. (1995). Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein. Nature 373, 523-527.
11. Hsiao, K., et al., & Cole, G. (1996). Correlative memory deficits, Aβ elevation, and amyloid plaques in transgenic mice. Science 274, 99-102.
12. Pike, C.J., Burdick, D., Walencewicz, A.J., Glabe, C.G. & Cotman, C.W. (1993). Neurodegeneration induced by β-amyloid peptides in vitro: The role of peptide assembly state. J. Neurosci. 13, 1676-1687.
13. Lorenzo, A. & Yankner, B.A. (1994). β-amyloid neurotoxicity requires fibril formation and is inhibited by Congo red. Proc. Natl Acad. Sci. USA 91, 12243-12247.
14. Iversen, L.L., Mortishire-Smith, R.J., Pollack, S.J. & Shearman, M.S. (1995). The toxicity in vitro of β-amyloid protein. Biochem. J. 311, 1-16.
15. Camilleri, P., Haskins, N.J. & Howlett, D.R. (1994). β-cyclodextrin interacts with the Alzheimer amyloid β-A4 peptide. FEBS Lett. 341, 256-258.
16. Tomiyama, T., et al., & Endo, N. (1996). Inhibition of amyloid β protein aggregation and neurotoxicity by rifampicin. J. Biol. Chem. 1996, 6839-6844.
17. Ghanta. J., Shen, C.-H., Kiessling, L.L. & Murphy, R.M. (1996). A strategy for designing inhibitors of β-amyloid toxicity. J. Biol. Chem. 271, 29525-29528.
18. Tjernberg, L.O., et al., & Nordstedt, C. (1996). Arrest of β-amyloid fibri formation by a pentapeptide ligand. J. Biol. Chem. 271, 8545-8548.
19. Tjernberg, L.O., et al., & Nordstedt, C. (1997). Controlling amyloid β-peptide fibril formation with protease-stable ligands. J. Biol. Chem. 272, 12601-12605.
20. Snyder, S.W., et al., & Holzman, T.F. (1994). Amyloid-β aggregation: Selective inhibition of aggregation in mixtures of amyloid with different chain lengths. Biophys. J. 67, 1216-1228.
21. Tomiyama, T., Asano, S., Furiya, Y., Shirasawa, T., Endo, N. & Mori, H. (1994). Racemization of Asp23 residue affects the aggregation properties of Alzheimer amyloid β protein analogues. J. Biol. Chem. 269, 10205-10208.
22. Soto, C., Castano, E.M., Frangione, B. & Inestrosa, N.C. (1995). The α-helical to β-strand transition in the amino-terminal fragment of the amyloid β-peptide modulates amyloid formation. J. Biol. Chem. 270, 3063-3067.
23. Wood, S.J., Maleeff, B., Hart, T. & Wetzel, R. (1996). Physical, morphological and functional differences between pH 5.8 and 7.4 aggregates of the Alzheimer's amyloid peptide Aβ. J. Mol. Biol. 256, 870-877.
24. Shen, C.L., Scott, G.L., Merchant, F. & Murphy, R.M. (1993). Light scattering analysis of fibril growth from the amino-terminal fragment β(1-28) of β-amyloid peptide. Biophys. J. 65, 2383-2395.
25. Shen, C.L., Fitzgerald, M.C. & Murphy, R.M. (1994). Effect of acid predissolution on fibril size and fibril flexibility of synthetic β-amyloid peptide. Biophys. J. 67, 1238-1246.
26. Shen, C.-H. & Murphy, R.M. (1995). Solvent effects on self-assembly of β-amyloid peptide. Biophys. J. 69, 640-651.
27. Lomakin, A., Chung, D.S., Benedek, G.B., Kirschner, D.A. & Teplow, D.B. (1996). On the nucleation and growth of amyloid β-protein fibrils: Detection of nuclei and quantitation of rate constants. Proc. Natl Acad. Sci. USA 93, 1125-1129.
28. Walsh, D.M., Lomakin, A., Benedek, G.B., Condron, M.M. & Teplow, D.B. (1997). Amyloid β-protein fibrillogenesis. J. Biol. Chem. 272, 22364-22372.
29. Hilbich, C., Kisters-Woike, B., Reed, J., Masters, C.L. & Beyreuther, K. (1991). Aggregation and secondary structure of synthetic amyloid βA4 peptides of Alzheimer's disease. J. Mol. Biol. 218, 149-163.
30. Barrow, C.J., Yasuda, A., Kenny, P.T. & Zagorski, M.G. (1992). Solution conformations and aggregational properties of synthetic amyloid β-peptides of Alzheimer's disease. Analysis of circular dichroism spectra. J. Mol. Biol. 225, 1075-1093.
31. Terzi, E., Hölzemann, G. & Seelig, J. (1995). Self-association of β-amyloid peptide (1-40) in solution and binding to lipid membranes. J. Mol. Biol. 252, 633-642.
32. Naiki, H. & Nakakuki, K. (1996). First-order kinetic model of Alzheimer's β-amyloid fibril extension in vivo. Lab. Invest. 74, 374-383.
33. Stine W.B.Jr., et al., & Krafft, G.A. (1996). The nanometer-scale structure of amyloid-β visualized by atomic force microscopy. J. Protein Chem. 15, 193-203.
34. Harper, J.D., Wong, S., Lieber, C.M. & Lansbury, P.T., Jr. (1997). Observation of metastable Aβ amyloid protofibrils by atomic force microscopy. Chem. Biol. 4, 119-125.
35. Harper, J.D., Lieber, C.M. & Lansbury, P.T., Jr. (1997). Atomic force microscopic imaging of seeded fibril formation and fibril branching by the Alzheimer's disease amyloid-β protein. Chem. Biol. 4, 951-959.
36. Burdick, D., et al., & Glabe, C. (1992). Assembly and aggregation properties of synthetic Alzheimer's A4/β amyloid peptide analogs. J. Biol. Chem. 267, 546-554.
37. Sweeney, P.J., Darker, J.G., Neville, W.A., Humphries, J. & Camilleri, P (1993). Electrophoretic techniques for the analysis of synthetic amyloid β-A4-related peptides. Anal. Biochem. 212, 179-184.
38. Garzon-Rodriguez, W., Sepulveda-Becerra, M., Milton, S. & Glabe, C.G. (1997). Soluble amyloid Aβ-(1-40) exists as a stable dimer at low concentrations. J. Biol. Chem. 272, 21037-21044.
39. LeVine, H., III. (1993). Thioflavine T interaction with synthetic Alzheimer's disease β-amyloid peptides: Detection of amyloid aggregation in solution. Protein Sci. 2, 404-410.
40. Magde, D., Elson, E.L. & Webb, W.W. (1972). Thermodynamic fluctuations in a reacting system. Measurement by fluorescence correlation spectroscopy. Phys. Rev. Lett. 29, 705-711.
41. Elson, E.L. & Magde, D. (1974). Fluorescence correlation spectroscopy. I. Conceptual basis and theory. Biopolymers 13, 1-27.
42. Ehrenberg, M. & Rigler, R. (1974). Rotational Brownian motion and fluorescence intensity fluctuation. Chem. Phys. 4, 390-401.
43. Rigler, R., Mets, Ü., Widengren, J. & Kask, P. (1993). Fluorescence correlation spectroscopy with high count rate and low background: Analysis of translational diffusion. Eur. Biophys. J. 22, 169-175.
44. Eigen, M. & Rigler, R. (1994). Sorting single molecules: Application to diagnostics and evolutionary biotechnology. Proc. Natl Acad. Sci. USA 91, 5740-5747.
45. Rigler, R. (1995). Fluorescence correlations, single molecule detection and large number screening. Applications in biotechnology. J. Biotech. 41, 177-186.
46. Tjernberg, L. (1997). Molecular Basis and Pharmacological Implications of Alzheimer Amyloid β-peptide Fibril Formation [PhD thesis], Karolinska Institute, Stockholm, Sweden.
47. Provencher, S.W. (1982). A constrained regulation method for inverting data represented by linear algebraic or integral equations. Computer Physics Commun. 27, 213-227.
48. Provencher, S.W. (1982). Contin: A general purpose constrained regulation program for inverting noisy linear algebraic and integral equations. Computer Physics Commun. 27, 229-242.
49. Schwille, P., Meyer-Almes, F.J. & Rigler, R. (1997). Dual-color fluorescence cross-correlation spectroscopy for multicomponent diffusional analysis in solution. Biophys. J. 72, 1878-1886.
50. Lundberg, K.M., Stenland C.J., Cohen, F.E., Prusiner, S.B. & Millhauser, G.L. (1997). Kinetics and mechanism of amyloid formation by the prion protein H1 peptide as determined by time-dependent ESR. Chem. Biol. 4, 345-355.
51. Kelly, J.W. (1996). Fibril structure. General discussion I. Ciba Foundation Symposium 199, p. 43, Wiley & Sons, Chichester, UK.
52. Soreghan, B., Kosmoski, J. & Glabe, C. (1994). Surfactant properties of Alzheimer's Aβ peptides and the mechanism of amyloid aggregation. J. Biol. Chem. 269, 28551-28554.
53. Jarrett, J.T., Berger, E.P. & Lansbury, P.T., Jr. (1993). The carboxyl terminus of the β amyloid protein is critical for the seeding of amyloid formation: Implications for the pathogenesis of Alzheimer's disease. Biochemistry 32, 4693-4697.
54. Evans, K.C., Berger, E.P., Cho, C.G., Weisgraber, K.H. & Lansbury, P.T., Jr. (1995). Apolipoprotein E is a kinetic but not a thermodynamic inhibitor of amyloid formation: Implications for the pathogenesis and treatment of Alzheimer's disease. Proc. Natl Acad. Sci. USA 92, 763-767.
55. Jarrett, J.T. & Lansbury, P.T., Jr. (1993). Seeding 'one-dimensional crystallization' of amyloid: A pathogenic mechanism in Alzheimer's disease and scrapie? Cell 73, 1055-1058.
56. Pitschke, M., Prior, R., Haupt, M. & Riesner, D. (1998). Detection of single amyloid β-protein aggregates in the cerebrospinal fluid of Alzheimer's patients by fluorescence correlation spectroscopy. Nat. Med. 4, 832-834.
57. de la Torre, J.G. & Bloomfield, V.A. (1981). Hydrodynamic properties of complex, rigid, biological macromolecules: Theory and applications. Q. Rev. Biophys. 14, 81-139.
58. Marquardt, D.W. (1963). An algorithm for least-squares estimation of nonlinear parameters. J. Soc. Indust. Appl. Math. 11, 431-441.